Repeated insulin shots at the same site can seed amyloid; consider this diagnosis if absorption seems erratic or glucose control worsens with a persistent lump.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Apollo endocrinologist explains the key difference between belly fat and visceral fat, warning that even people with normal ...

MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care through ...

Oclaiz is a subcutaneous long-acting octreotid depot, designed for optimized disease control and convenient self-administration. The product is based on Camurus' FluidCrystal technology and is ...

Excess abdominal fat, particularly visceral fat, actively triggers morning blood sugar spikes by causing liver insulin ...

Participants regained their original weight within an average of 1.7 years after stopping any type of weight loss medication.

CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products: insulin glargine-yfgn ...

Industry Trends and Global Forecasts, Till 2035" report has been added to ResearchAndMarkets.com's offering. The global GLP-1 market is estimated to grow from USD 62.2 billion in the current year to ...

New obesity criteria that add waist and body fat measures to BMI could classify nearly 70% of U.S. adults as obese, according ...

Combination of AT7687 and cagrilintide demonstrated enhanced weight loss effect in obese, insulin-resistant, pre-diabetic non ...

Regular walking supports loss of visceral fat, a harmful type of fat linked to chronic disease risk. Whether in the morning ...